NO920024L - PREPARATIONS AND PROCEDURES FOR AA PREVENT FLUOROSE - Google Patents
PREPARATIONS AND PROCEDURES FOR AA PREVENT FLUOROSEInfo
- Publication number
- NO920024L NO920024L NO92920024A NO920024A NO920024L NO 920024 L NO920024 L NO 920024L NO 92920024 A NO92920024 A NO 92920024A NO 920024 A NO920024 A NO 920024A NO 920024 L NO920024 L NO 920024L
- Authority
- NO
- Norway
- Prior art keywords
- fluoride
- monofluorophosphate
- fluorosis
- ingested
- fluorose
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Et fluorosefritt, spiselig fluorioninneholdende preparat om- fattende en blanding av farmasøytisk akseptabelt fluorid og monofluorfosfat i et vektforhold for å tilveiebringe ikke mer enn 50 %, og fortrinnsvis ikke mer enn 25 %, tilgjengelige fluorioner fra fluoridet og balansen fra mono- fluorfosfatet. Med "fluorosefritt" pre- parat er ment et preparat som, når det inntas, minimaliserer eller forebygger forekomsten av fluorose som er en van- lig effekt når fluor inntas. Preparatet kan inneholde ytterligere farmasøytisk akseptable adjuvanser, slik som vit- aminer, fargestoffer, smaksstoffer, bærere, stabiliseringsmidler, konser- veringsmidler og medikamenter, og kan foreligge i form av et pulver, tablett, kapsel, pille eller en væske i en egnet spiselig bærer. Foretrukne forbindelser er alkalimetall-, ammonium- og amin- fluorider og monofluorfosfater. De mest foretrukne forbindelser er natrium- fluorid (NaF) og natriummonofluorfosfat (MFP), hvis formel er Na2FP03, og de tilsvarende kaliumsalter. Preparatene er spesielt til- passet anvendelse som et kosttilskudd for vesentlig umiddelbart å tilveie- bringe lave doseringer av fluorioner fra fluoridforbindelsen ved inntak, og en langsom, forlenget frigivelse av fluorioner fra monofluorfosfatet.A fluorose-free, edible fluoride-containing composition comprising a mixture of pharmaceutically acceptable fluoride and monofluorophosphate in a weight ratio to provide no more than 50%, and preferably not more than 25%, available fluoride ions from the fluoride and the balance from the monofluorophosphate. By "fluorosis-free" preparation is meant a preparation which, when ingested, minimizes or prevents the occurrence of fluorosis which is a common effect when fluoride is ingested. The composition may contain additional pharmaceutically acceptable adjuvants, such as vitamins, dyes, flavors, carriers, stabilizers, preservatives and medicaments, and may be in the form of a powder, tablet, capsule, pill or liquid in a suitable edible carrier. . Preferred compounds are alkali metal, ammonium and amine fluorides and monofluorophosphates. The most preferred compounds are sodium fluoride (NaF) and sodium monofluorophosphate (MFP), whose formula is Na2FP03, and the corresponding potassium salts. The compositions are particularly adapted for use as a dietary supplement to provide substantially immediate doses of fluoride ions from the fluoride compound upon ingestion, and a slow, prolonged release of fluoride ions from the monofluorophosphate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO92920024A NO920024L (en) | 1992-01-02 | 1992-01-02 | PREPARATIONS AND PROCEDURES FOR AA PREVENT FLUOROSE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO92920024A NO920024L (en) | 1992-01-02 | 1992-01-02 | PREPARATIONS AND PROCEDURES FOR AA PREVENT FLUOROSE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO920024D0 NO920024D0 (en) | 1992-01-02 |
| NO920024L true NO920024L (en) | 1993-07-05 |
Family
ID=19894739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92920024A NO920024L (en) | 1992-01-02 | 1992-01-02 | PREPARATIONS AND PROCEDURES FOR AA PREVENT FLUOROSE |
Country Status (1)
| Country | Link |
|---|---|
| NO (1) | NO920024L (en) |
-
1992
- 1992-01-02 NO NO92920024A patent/NO920024L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO920024D0 (en) | 1992-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5264446A (en) | Solid medicament formulations containing nifedipine, and processes for their preparation | |
| EP1061892B1 (en) | Remineralization of teeth | |
| NO823144L (en) | Anticarious COMPOSITION. | |
| CA2168732A1 (en) | Gelatin Capsules Containing a Highly Concentrated Acetaminophen Solution | |
| NZ198285A (en) | Solid pharmaceutical compositions containing a specific form of nifedipine crystals | |
| RU2412688C2 (en) | Stabilised oxygen-release composition | |
| HUP9701690A2 (en) | Tetrahydrofuran derivatives as antifungals and pharmaceutical compositions containing the same | |
| SE469208B (en) | STABLE VAETEPEROXIDE RELEASING TOOTH CREAM | |
| GR3001284T3 (en) | Pharmaceutical composition containing ibuprofen and aluminium hydroxide | |
| JPS6061524A (en) | Treatment for tooth socket bone absorption | |
| ES8106654A1 (en) | Pharmaceutical composition containing Sanguinaria and Galangal suitable for treatment of periodentitis and tumours. | |
| SE448816B (en) | ORAL COMPOSITION FOR THE PROMOTION OF ORAL HYGIENE | |
| JPS58134031A (en) | Dihydrocyclosporin d for treating multiple screlosis | |
| DK162252B (en) | ORAL CARE WITH ANTIGINGIVITIS EFFECT | |
| US4888343A (en) | Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process | |
| US4774077A (en) | Stable antiplaque dentifrice | |
| JP3122748B2 (en) | Antipyretic analgesic containing ibuprofen | |
| CA2086565A1 (en) | Pharmaceutical composition for treating pigmentation | |
| GR1001380B (en) | Fluorosis-free ingestible fluoride ion-containing composition | |
| NO920024L (en) | PREPARATIONS AND PROCEDURES FOR AA PREVENT FLUOROSE | |
| US2449184A (en) | Oral fluoride-vitamin preparation | |
| US3639636A (en) | Method of lowering serum cholesterol | |
| CA2014377A1 (en) | Composition | |
| JPS648602B2 (en) | ||
| JPS63141921A (en) | Composition for oral cavity application |